Hosted by the British Association for Cancer Research

Since the BACR was founded, an ever increasing number of cancer therapeutics are becoming available and dramatic clinical responses are being achieved in subsets of patients with previously intractable disease. This meeting will bring together cancer researchers from academia and industry to focus on two research topics that are fundamental to ensuring that both established and novel treatments can be applied to bring maximum benefit for cancer patients:

(1) How can we predict in advance which patients will benefit from a given treatment?
(2) How can we anticipate, monitor and prevent the evolution of drug resistance in cancer?

We have an exceptional line-up of internationally-renowned invited speakers, covering the discovery of novel targets and resistance mechanisms in cancer cells, to analysis of the tumour microenvironment, the clinical development of immunotherapies and the use of liquid biopsies for disease monitoring.

Abstract submission deadline: 16 July 2021

Registration

• Registration deadline: 20 August 2021
• Registration costs between £10 for students members to £25 for non-members

All information on the event website, https://www.bacr.org.uk/event/response-and-resistance-in-cancer-therapy/introduction.